Currentblue cross blue shield - louisianaPolicy AHS - G2099 - Intracellular Micronutrient Analysis, 1

Intracellular Micronutrient Analysis

Policy governing coverage determination for intracellular micronutrient panel testing (proprietary intracellular assays) for members of Blue Cross and Blue Shield of Louisiana.

Policy Summary

Payerblue cross blue shield - louisiana

PolicyIntracellular Micronutrient Analysis

Policy CodePolicy AHS - G2099 - Intracellular Micronutrient Analysis, 1

Change TypeNo material change

Effective Date05/15/2022

Next Review Date

Key ActionDo not submit claims for intracellular micronutrient panel testing (e.g., SpectraCell, CMA, ExaTest) as these tests do not meet coverage criteria.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

1policy version

07/01/2025current effective

07/01/2025most recent review

SpectraCell, ExaTest, CMA, NutrEvalproprietary tests

23references

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Determination — Intracellular Micronutrient Panels

Not covered due to lack of evidence

Primary coverage determination: Intracellular micronutrient panel testing (e.g., SpectraCell, Cell Science Systems CMA, ExaTest) is considered not medically necessary and does not meet coverage criteria due to insufficient published scientific literature demonstrating required benefit for diagnosis or treatment.

Intracellular micronutrient panel testing (proprietary assays such as SpectraCell, Cell Science Systems Cellular Micronutrient Assay, ExaTest) is specifically excluded from coverage. These tests are considered to not meet coverage criteria because there is insufficient published scientific literature demonstrating that the tests are required and beneficial for diagnosis or treatment.

Revision history notes indicate multiple literature reviews (most recently on 07/01/2025) were performed and did not necessitate any modifications to the coverage criteria. Summaries from 10/01/2024, 06/01/2023, and 01/01/2023 similarly state that literature reviews did not require changes to coverage.

No studies were identified that evaluate the accuracy or clinical utility of intracellular micronutrient testing compared with standard serum testing, and no controlled studies were found that demonstrate changes in patient management or health outcomes attributable to these tests. Limited data exist on correlations between serum and intracellular levels, and no clinical practice guidelines recommending intracellular testing were identified.

Covered Indications

None specified as covered in this policy window.

Covered indications: None specified as covered in this policy window. The policy notes that these tests are offered as laboratory-developed tests (LDTs) in CLIA‑accredited laboratories and have not undergone FDA approval.

References and vendor/sample reports listed but no covered clinical indications enumerated

References and vendor/sample reports are listed but no covered clinical indications are enumerated.

Supporting references and vendor materials: The policy cites evidence-based references and vendor/sample reports (e.g., SpectraCell sample report, ExaTest technical process, Vibrant and Genova sample reports) but does not identify clinical indications for which intracellular micronutrient testing is covered.

Not Covered Services

Intracellular micronutrient panel testing (for example, SpectraCell, Cell Science Systems CMA, ExaTest) does not meet coverage criteria and is considered not medically necessary due to lack of sufficient published evidence demonstrating diagnostic or therapeutic benefit.

Vendor sample reports and proprietary test names (for example, SpectraCell, EXA Test, Vibrant, Genova Diagnostics NutrEval, Cell Science Systems materials) are cited in the evidence section and reference list, but these source materials do not provide evidence of clinical utility or identify indications that would meet coverage criteria.

Referenced Procedure Codes

Referenced Procedure CodesCPT

82128	Amino acids; multiple, qualitative, each specimen.
82136	Amino acids, 2 to 5 amino acids, quantitative, each specimen
82180	Ascorbic acid (vitamin c), blood.
82310	Calcium; total.
82379	Carnitine (total and free), quantitative each specimen.
82495	Chromium.
82525	Copper.
82607	Cyanocobalamin (Vitamin B-12);
82652	Vitamin D; 1, 25 dihydroxy, includes fraction(s), if performed.
82725	Fatty acids, nonesterified.

1–10 of 25

1/3

Provider Action & Billing Implications

Denial Risk

Coverage and Billing Implications

Intracellular micronutrient panel testing (e.g., SpectraCell, Cell Science Systems cell micronutrient assay, ExaTest) does not meet coverage criteria and claims for these tests are subject to denial.

Affected codes include (but may not be limited to): 82128, 82136, 82180, 82310, 82379, 82495, 82525, 82607, 82652, 82725, 82746, 82748, 82978, 83735, 83785, 84207, 84252, 84255, 84425, 84446, 84590, 84591, 84597, 84630, 86353, 88348.

Prior Authorization

Prior authorization is not specified in the provided policy text. Providers should verify member benefit coverage and any applicable prior authorization requirements through the payer's normal claim/authorization channels before ordering testing.

No prior authorization requirement is stated in the policy revision history or coverage sections.

Note

Government Policy Precedence

If there is a conflict between this policy and applicable government policy (e.g., LCDs, NCDs, or state Medicaid rules), the government policy takes precedence. Providers should follow LCD/NCD or state Medicaid determinations where applicable.

Note

Revision History and Literature Review

Revision history: summaries indicate periodic literature review with no changes to coverage criteria since initial implementation. Providers should note that literature reviews on 06/01/2023, 10/01/2024 and 07/01/2025 did not necessitate modifications to coverage criteria.

Ordering and Test Availability

Note

Ordering requirements — no provider restrictions listed

No specific ordering provider restrictions (who may order the test) are stated in the policy; the document notes that these tests are offered as laboratory‑developed tests in CLIA‑accredited laboratories.

Tests are offered by SpectraCell, IntraCellular Diagnostics, and Cell Science Systems in CLIA‑accredited labs; no clinician ordering limits are specified.

Note

Ordering requirements — who may order is not specified

The policy text does not specify which provider types are authorized to order intracellular micronutrient panels; the document contains no stated ordering‑clinician limitations.

Multiple vendor references and review history are provided, but none define who may order testing.

Frequency Limits

NutrEval FMV (referenced)

Test referencedGenova Diagnostics NutrEval FMV

Frequency ruleNo frequency limit specified in policy

Age range noted by vendorAvailable for patients 2 years and older (per vendor description)

Frequency limits (placeholder)

Frequency limits placeholderNo frequency rules specified in the policy or review notes

Review historyLiterature reviews (07/01/2025, 10/01/2024, 06/01/2023, 01/01/2023) did not necessitate modifications to coverage criteria

Operational notePolicy provides no periodic testing interval for intracellular micronutrient assays

Definitions and Terms

CMA definition

AcronymCMA = Cellular micronutrient assay (Cell Science Systems)

Vendor associationCMA is identified with Cell Science Systems (CSS)

ContextListed in terminology table as a proprietary cellular micronutrient assay

Laboratory terminology

ASEMAnalytical scanning electron microscopy

EXAEnergy dispersive x-ray analysis

LDTsLaboratory-developed tests

CLIAClinical Laboratory Improvement Amendments

Referenced micronutrient / cellular nutrition assays and laboratory analyses

SpectraCellSpectraCell micronutrient/Cellular Nutrition panel and sample laboratory report referenced

Genova Diagnostics NutrEvalGenova Diagnostics NutrEval FMV referenced (comprehensive blood and urine test)

VibrantVibrant Micronutrient sample report referenced

EXA TestEXA Test / full spectrum mineral analysis technical process referenced

Cell Science SystemsCell Science Systems cellular nutrition assays / ALCAT referenced

Background

Micronutrients (vitamins and trace elements) are essential for metabolic and enzymatic functions, and deficiencies can occur in certain populations (for example, individuals with malabsorption, severe dietary restriction, or other risk factors). Standard assessment of micronutrient status is typically performed using serum or plasma measurements. Intracellular assays purport to assess cellular stores (e.g., lymphocytes or buccal cells) to reflect longer-term or tissue-specific nutrient status, but the policy review found limited data supporting correlation with serum measures or established clinical benefit.

Revision History & References

2025-07-01literature_review_updatedLatest

Reviewed and updated background, guidelines, recommendations, and evidence-based references; literature review did not necessitate modifications to coverage criteria.

2024-10-01literature_review

Literature review did not necessitate any modifications to coverage criteria.

2023-06-01literature_review_and_edit

Literature review did not necessitate changes to coverage criteria; policy edited for clarity and consistency.

2023-01-01literature_review

Literature review did not necessitate modification to coverage criteria.

2022-05-15initial_implementation

Initial policy implementation.

References and related vendor reports

Scientific references countMultiple evidence-based references and vendor reports cited (see reference list entries 1–24)

Vendor/sample reportsSpectraCell sample report; Vibrant sample report; Genova NutrEval product page; EXA technical process; Cell Science Systems assays

Selected articles and studiesIncludes observational and review articles (e.g., Houston 2010; Steele 2020; Coelho 2020)

Revision history linkageReferences were updated in the 07/01/2025 review without changes to coverage criteria

Policy Summary

Payerblue cross blue shield - louisiana

PolicyIntracellular Micronutrient Analysis

Policy CodePolicy AHS - G2099 - Intracellular Micronutrient Analysis, 1

Change TypeNo material change

Effective Date05/15/2022

Next Review Date

Key ActionDo not submit claims for intracellular micronutrient panel testing (e.g., SpectraCell, CMA, ExaTest) as these tests do not meet coverage criteria.

SourceLink

On This Page